Show simple item record

Autoimmune acute liver failure: Proposed clinical and histological criteria

dc.contributor.authorStravitz, R. Todden_US
dc.contributor.authorLefkowitch, Jay H.en_US
dc.contributor.authorFontana, Robert Johnen_US
dc.contributor.authorGershwin, M. Ericen_US
dc.contributor.authorLeung, Patrick S. C.en_US
dc.contributor.authorSterling, Richard K.en_US
dc.contributor.authorManns, Michael P.en_US
dc.contributor.authorNorman, Gary L.en_US
dc.contributor.authorLee, William M.en_US
dc.date.accessioned2011-02-02T17:57:59Z
dc.date.available2012-03-05T15:30:01Zen_US
dc.date.issued2011-02en_US
dc.identifier.citationStravitz, R. Todd; Lefkowitch, Jay H.; Fontana, Robert J.; Gershwin, M. Eric; Leung, Patrick S. C.; Sterling, Richard K.; Manns, Michael P.; Norman, Gary L.; Lee, William M. (2011). "Autoimmune acute liver failure: Proposed clinical and histological criteria" Hepatology 53(2): 517-526. <http://hdl.handle.net/2027.42/79410>en_US
dc.identifier.issn0270-9139en_US
dc.identifier.issn1527-3350en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/79410
dc.description.abstractIdentifying autoimmune hepatitis as the etiology of acute liver failure (ALF) is potentially important, because administering corticosteroids might avoid the need for liver transplantation. However, clinical and histological criteria of autoimmune ALF (AI-ALF) have not been defined. Liver sections (biopsies and explants) from a 72-patient subset of the ALF Study Group Registry with indeterminate ALF were reviewed by a pathologist blinded to all clinical data and were diagnosed with probable AI-ALF based on four features suggestive of an autoi mmune pathogenesis: distinctive patterns of massive hepatic necrosis (present in 42% of sections), presence of lymphoid follicles (32%), a plasma cell–enriched inflammatory infiltrate (63%), and central perivenulitis (65%). Forty-two sections (58%) were considered probable for AI-ALF; this group demonstrated higher serum globulins (3.7 ± 0.2 g/dL versus 3.0 ± 0.2 g/dL; P = 0.037) and a higher prevalence of antinuclear and/or anti–smooth muscle antibodies (73% versus 48%; P = 0.034) compared to those without histology suggestive of probable AI-ALF. Thirty patients concordant for autoantibodies and probable AI-ALF upon histological analysis were more likely to have the classical autoimmune hepatitis phenotype (female predominance [72% versus 48%; P < 0.05], higher globulins [3.9 ± 0.2 g/dL versus 3.0 ± 0.2 g/dL; P < 0.005], and higher incidence of chronic hepatitis in long-term follow-up [67% versus 17%, P = 0.019]) compared to the population without concordant AI-ALF histology and autoantibodies. Conclusion: Patients with indeterminate ALF often have features of autoimmune disease by histological analysis, serological testing, and clinical recurrence during follow-up. In contrast to classical autoimmune hepatitis, histological features of AI-ALF predominate in the centrilobular zone. (H EPATOLOGY 2011;53:517-526)en_US
dc.format.extent623356 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherHepatologyen_US
dc.titleAutoimmune acute liver failure: Proposed clinical and histological criteriaen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Gastroenterology, University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationotherSection of Hepatology, Virginia Commonwealth University, Richmond, VA ; These authors contributed equally to this work. ; fax: 804-828-4945 ; Section of Hepatology, Hume-Lee Transplant Center, Virginia Commonwealth University, P.O. Box 980341, Richmond, VA 23298-0341en_US
dc.contributor.affiliationotherDepartment of Pathology, Columbia University, New York, NYen_US
dc.contributor.affiliationotherDivision of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Davis, CAen_US
dc.contributor.affiliationotherDivision of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Davis, CAen_US
dc.contributor.affiliationotherSection of Hepatology, Virginia Commonwealth University, Richmond, VAen_US
dc.contributor.affiliationotherDepartment of Gastroenterology, Hepatology, and Endocrinology, Hannover Medical School, Hannover, Germanyen_US
dc.contributor.affiliationotherINOVA Diagnostics, Inc., San Diego, CAen_US
dc.contributor.affiliationotherDivision of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, TXen_US
dc.identifier.pmid21274872en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/79410/1/24080_ftp.pdf
dc.identifier.doi10.1002/hep.24080en_US
dc.identifier.sourceHepatologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.